Correlating Receptor Status with Nottingham Prognostic Index in Breast Cancer

被引:0
|
作者
Gupta, Rohan [1 ]
Khanna, Rahul [1 ]
Kar, Amrita G. [2 ]
Khanna, Seema [1 ]
Khanna, Siddharth [3 ]
Meena, Ram Niwas [1 ]
机构
[1] Banaras Hindu Univ, Inst Med Sci, Dept Surg, Varanasi 221005, India
[2] Banaras Hindu Univ, Inst Med Sci, Dept Pathol, Varanasi 221005, India
[3] Aligarh Muslim Univ, Dept Ophthalmol, Aligarh 202002, India
关键词
Breast cancer; Nottingham Prognostic Index; Receptor status;
D O I
10.1007/s12262-023-03865-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
The biological behavior and prognosis of breast cancer is often unpredictable with a number of factors contributing to the outcome. Nottingham's Prognostic Factor (NPI) takes into account the tumor size, nodal status, and histological grade of tumor. The receptor status considers the hormone receptor and HER2 status. The aim of the study was to correlate the NPI score with the receptor status expression in Indian women with breast cancer. A total of 78 breast cancer patients who underwent upfront modified radical mastectomy were recruited. NPI score and receptor status assessment was done at histopathological examination of the specimen. Hormone receptor negative breast cancer tended to have a higher NPI score compared to hormone receptor positive patients. However, this difference did not achieve statistical significance. NPI score parameters except for the histological grade are a reflection of the duration or time span of the tumor. On the contrary, the receptor status is indicative of the tumor biology and not of its time duration. A scoring system which incorporates the three parameters of the NPI as well as the receptor status would be the best prognostic index as well as predictive regarding the choice of adjuvant therapy.
引用
收藏
页码:344 / 347
页数:4
相关论文
共 50 条
  • [21] Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression
    Kurshumliu, Fisnik
    Gashi-Luci, Lumturije
    Kadare, Shahin
    Alimehmeti, Mehdi
    Gozalan, Ugur
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [22] Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
    Masarwah, Amro
    Auvinen, Paivi
    Sudah, Mazen
    Dabravolskaite, Vaiva
    Arponen, Otso
    Sutela, Anna
    Oikari, Sanna
    Kosma, Veli-Matti
    Vanninen, Ritva
    BMC CANCER, 2016, 16
  • [23] A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer
    Tan, Weige
    Luo, Wei
    Jia, Weijuan
    Liang, Gehao
    Xie, Xinhua
    Zheng, Wenbo
    Song, Erwei
    Su, Fengxi
    Gong, Chang
    ONCOTARGET, 2016, 7 (52) : 87312 - 87322
  • [24] Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
    Amro Masarwah
    Päivi Auvinen
    Mazen Sudah
    Vaiva Dabravolskaite
    Otso Arponen
    Anna Sutela
    Sanna Oikari
    Veli-Matti Kosma
    Ritva Vanninen
    BMC Cancer, 16
  • [25] Retracted Article: Prognostic Factors in Breast Cancer: The Value of the Nottingham Prognostic Index for Patients Treated in a Single Institution
    Homa Okugawa
    Daigo Yamamoto
    Yoshiko Uemura
    Noriko Sakaida
    Masanori Yamada
    Kanji Tanaka
    Yasuo Kamiyama
    Surgery Today, 2005, 35 : 907 - 911
  • [26] IVIM and DCE-MRI in Predicting Phenotypic Subtypes and Nottingham Prognostic Index of Breast Cancer
    Sun, Zhanguo
    Zhou, Zhe
    Wang, Lei
    Zhu, Laimin
    Chen, Yueqin
    Liu, Qiaolu
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (04): : 400 - 406
  • [27] Correlation Between Oncotype DX, PREDICT and the Nottingham Prognostic Index: Implications for the Management of Early Breast Cancer
    Hillyar, Christopher
    Rizki, Hirah
    Abbassi, Omar
    Miles-Dua, Sascha
    Clayton, Gillian
    Gandamihardja, Tasha
    Smith, Simon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [28] Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999
    Blamey, R. W.
    Ellis, I. O.
    Pinder, S. E.
    Lee, A. H. S.
    Macmillan, R. D.
    Morgan, D. A. L.
    Robertson, J. F. R.
    Mitchell, M. J.
    Ball, G. R.
    Haybittle, J. L.
    Elston, C. W.
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (10) : 1548 - 1555
  • [29] PROGNOSTIC FACTORS - STAGE AND RECEPTOR STATUS IN BREAST-CANCER
    DONEGAN, WL
    CANCER, 1992, 70 (06) : 1755 - 1764
  • [30] Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
    E A Rakha
    D Soria
    A R Green
    C Lemetre
    D G Powe
    C C Nolan
    J M Garibaldi
    G Ball
    I O Ellis
    British Journal of Cancer, 2014, 110 : 1688 - 1697